LifeStance Therapists & Psychiatrists Taylor
20500 Eureka Road, Suite 200, Taylor
4.3(310 Google reviews)
United States
2 listed treatment centers serving Taylor and the surrounding area.
20500 Eureka Road, Suite 200, Taylor
4.3(310 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Taylor.
3.5 miles away · Dearborn
3.5 miles away · Dearborn
6 miles away · Dearborn Heights
2222 North Beech Daly Road, Suite 1, Dearborn Heights
4.8(40 Google reviews)
6.1 miles away · Dearborn
290 Town Center Drive, Suite 141, Dearborn
4.6(48 Google reviews)
6.4 miles away · Wayne
10.8 miles away · Livonia
Before starting treatment, ask for an estimate that separates the medication from the supervised treatment and monitoring visit. Both may be billed, and your share depends on your benefits, deductible, network rules, and how the center submits claims. A medication benefit check alone may not explain the full cost of treatment.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took, how long you took them, and your response. Ask the treatment center who gathers these records, submits the request, and handles requests for additional information. Authorization does not necessarily mean every charge will be paid.
Medicare may cover Spravato through Part B or Part D, depending on the plan and treatment setting. Michigan Medicaid coverage also depends on the plan and setting. The two Taylor directory listings currently indicate that they do not accept Medicare or Medicaid; confirm this directly because directory information can change. Program coverage and a center's willingness to accept that coverage are separate questions.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Ask about current eligibility rules and which charges any assistance applies to.
Before scheduling, ask the center and insurer:
SPRAVATO® must be given in a healthcare setting certified through the SPRAVATO® REMS program. You self-administer the nasal spray under direct observation by a healthcare provider; it is never sent home with you. Taylor has two directory listings offering Spravato, but their REMS certification status is not recorded in the supplied listings. Confirm certification directly before scheduling.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume that a particular frequency is guaranteed.
Plan for a substantial appointment: monitoring alone lasts at least two hours after each dose, and preparation or additional observation may extend your time at the center. Ask about the full appointment window before arranging work leave, childcare, or other responsibilities. Recurring appointments may make it helpful to discuss predictable time off with your employer without sharing more medical information than you want to.
Arrange for someone else to drive you home after every treatment. You must not drive or operate machinery until the next day after restful sleep. Ask the center about its pickup requirements, whether a support person must accompany you, and what happens if your ride cancels.
If you cannot find an available, confirmed certified center in Taylor, directory listings also exist in Ann Arbor, Novi, Troy, St. Clair Shores, Lansing, Flint, Kalamazoo, and Grand Rapids. These are search options, not confirmation of certification, appointment availability, or insurance acceptance.
This directory lists two Taylor locations offering Spravato, but their REMS certification status is not recorded in the available information. Ask each location to confirm that treatment takes place in a currently REMS-certified setting. Also check appointment availability, insurance acceptance, and transportation requirements. A directory listing alone does not establish certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your history and safety considerations; having depression does not automatically establish eligibility.
Coverage depends on your plan and treatment setting. Medicare Part B or Part D and Michigan Medicaid may cover treatment in some circumstances, but the two Taylor listings currently indicate that they do not accept Medicare or Medicaid. Confirm directly with the center and your insurer. Ask separately about the medication, monitoring visit, network participation, and prior authorization.
You use the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. After the dose, staff monitor you for at least two hours for effects such as sedation, dissociation, breathing problems, and blood pressure increases. The full appointment may take longer. Arrange a ride home, and do not drive until the next day after restful sleep.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history and medicines with the prescriber, and report concerning symptoms during monitoring.
Do not wait for a treatment appointment to get urgent help. In a crisis, call or text 988; call 911 if there is immediate danger. Spravato has not been demonstrated to prevent suicide or reduce suicidal thoughts or behavior. Even when prescribed for depressive symptoms associated with an acute suicidal crisis, it does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.